Is Quest Diagnostics a Great Dividend Stock?
The current coronavirus pandemic has put the U.S. healthcare system under a microscope and emphasized the importance of diagnostic testing. Quest Diagnostics (NYSE: DGX), a leader in both developing and conducting such tests -- including for COVID-19 -- aims to expand its testing reach while rewarding shareholders with ever-increasing dividends.
Image Source: Getty Images.
In 2019, Quest distributed $2.12 per share to its stockholders. The board of directors then authorized a 5.7% increase in the dividend, marking the ninth increase since 2011. Now investors can receive $0.56 quarterly or $2.24 for the full year in 2020. Based on the current stock price of approximately $82, the dividend yields about 2.7%.
Source Fool.com
